Gonadotropin‐releasing hormone agonist treatment and ischemic heart disease among female patients with breast cancer: A cohort study

BACKGROUND: The risk of ischemic heart disease (IHD) due to the impact of gonadotropin‐releasing hormone (GnRH) agonists among female patients with breast cancer remains a controversy. METHODS: Information from the Registry for Catastrophic Illness, the National Health Insurance Research Database (N...

Descripción completa

Detalles Bibliográficos
Autores principales: Chou, Yi‐Sheng, Wang, Chun‐Chieh, Hsu, Li‐Fei, Chuang, Pei‐Hung, Cheng, Chi‐Feng, Li, Nai‐Hsin, Chen, Chu‐Chieh, Chen, Chien‐Liang, Lai, Yun‐Ju, Yen, Yung‐Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028063/
https://www.ncbi.nlm.nih.gov/pubmed/36305849
http://dx.doi.org/10.1002/cam4.5390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028063/
https://www.ncbi.nlm.nih.gov/pubmed/36305849
http://dx.doi.org/10.1002/cam4.5390

Ejemplares similares